Life Science Company
Icagen has acquired 1 company of its own, including 1 in the last 5 years. It has also divested 1 asset.
It’s largest disclosed sale occurred in 2020, when it sold Icagen - North Carolina Operations to Ligand Pharmaceuticals for $15M. Icagen has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Icagen’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1